General Motors will spend $877 million to upgrade a truck factory in Flint, Mich., amid solid demand for the auto maker’s Chevrolet and GMC full-size pickups.
Freddie Mac’s big profit masked small earnings in its core business.
Strong Eylea sales sent Regeneron stock—and future expectations—ever higher.
Sprint’s fiscal first-quarter results showed better subscriber numbers and churn, but the company’s fundamental challenges remain.
Shire is venturing into bigger, riskier deal making with its $31 billion unsolicited bid to buy U.S. biotech Baxalta.
Scott Bessent will start his own hedge-fund firm, with a $2 billion investment from Soros Fund Management.
The market’s reaction to Chesapeake Energy’s dividend cut has provided a buying opportunity and potentially makes the company attractive to an acquirer.
A federal judge rejected a proposed $79 million class-action settlement between American Express and a group of merchants, citing a recent discovery that two opposing lawyers in the case had exchanged confidential documents.
Shire made an unsolicited $30.6 billion offer for rare-disease treatment maker Baxalta, becoming the latest deal-hungry company refusing to take “no” for an answer amid the current deal boom.
Etsy Inc., an online marketplace for handmade and vintage goods, saw its second-quarter loss sharply widened, as higher expenses hampered results.